Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5258533 | 0.92 | SLC2A1 (0.57) | SLC2A1KCNH2 | |
| SCHEMBL3273210 | 0.90 | SLC2A1 (0.64) | SLC2A1KCNH2 | |
| SCHEMBL5258451 | 0.82 | SLC2A1 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL5434435 | 0.80 | KCNH2 (0.52) | SLC2A1KCNH2 | |
| SCHEMBL3277881 | 0.77 | SLC2A1 (0.70) | SLC2A1KCNH2 | |
| SCHEMBL5262950 | 0.76 | SLC2A1 (0.63) | SLC2A1KCNH2 | |
| SCHEMBL5257893 | 0.76 | KCNH2 (0.53) | SLC2A1KCNH2 | |
| SCHEMBL3277946 | 0.75 | SLC2A1 (0.76) | SLC2A1KCNH2 | |
| SCHEMBL5426713 | 0.73 | KCNH2 (0.72) | SLC2A1KCNH2 | |
| SCHEMBL5258903 | 0.73 | KCNH2 (0.55) | SLC2A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070254872-A1 | Antibacterial Agents | GLAXO GROUP LIMITED (GB) | 2007-11-01 | — | — | US | claimed |
| US-20070254872-A1 | Antibacterial Agents | GLAXO GROUP LIMITED (GB) | 2007-11-01 | — | — | US | disclosed |
| US-20070254872-A1 | Antibacterial Agents | GLAXO GROUP LIMITED (GB) | 2007-11-01 | — | — | US | disclosed |
| US-20070254872-A1 | Antibacterial Agents | GLAXO GROUP LIMITED (GB) | 2007-11-01 | — | — | US | disclosed |
| EP-1773831-A1 | ANTIBACTERIAL AGENTS | GLAXO GROUP LIMITED (GB) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006014580-A1 | ANTIBACTERIAL AGENTS | GLAXO GROUP LIMITED (GB) | 2006-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254872-A1 | Antibacterial Agents | NQO2, NQO1, NDUFV2 | SLC2A1 4018/4885KCNH2 2586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.